Report cover image

Global Radiodermatitis Market Size, Trends & Growth Opportunity By Product (Oral, and Dressings), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region and Forecast till 2027

Publisher QualiKet Research
Published Feb 11, 2023
Length 141 Pages
SKU # QUA17762579

Description

Global Radiodermatitis Market Size, Trends, & Growth Opportunity by Product (Oral, Dressings), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, and Forecast till 2027.

Global Radiodermatitis Market

The global radiodermatitis market was valued at USD 4362.5 million in 2021 which is expected to reach USD 674.22 million by 2027, at a CAGR 9.09 % from 2022-2027.

Radiation dermatitis, X-ray dermatitis, and radiation injury are all names for radiodermatitis. It is an unintended consequence of external beam ionising radiation. Radiotherapy is used to treat cancer or other disorders, which is the most common cause of radiothermatitis.

Market Drivers

The rise in cancer prevalence is the primary driving factor projected to increase the worldwide radiodermatitis market's growth. For example, the American Cancer Society estimates that in 2019, around 1,762,450 cancer cases will be identified and approximately 606,880 cancer deaths will occur in the United States. Furthermore, increased research & development of new medicines for radiodermatitis therapy will positively benefit global radiodermatitis market growth. Furthermore, investments in raising awareness about radiation-induced skin damage are likely to fuel the worldwide radiodermatitis market's expansion.

Market Restraints

However, the high cost of dressings such as honey-impregnated dressing and silicone dressing is projected to limit the worldwide radiodermatitis market's growth.

Market Segmentation

Global Radiodermatitis Market is segmented into products such as topical (corticosteroids, hydrophilic creams, antibiotics, and others), Oral, and Dressings (No Sting barrier film, Silicone Coated dressings, Honey impregnated gauze, and Others). Further, Global Radiodermatitis Market is segmented into distribution channel such as Hospital Pharmacy, Retail Pharmacy, and Others.

Regional analysis

Also, Global Radiodermatitis Market is segmented into five regions, such as North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.

Market Key Players

Various key players are discussed in this report, such as Jay Pharma, Smith & Nephew Plc, Stratpharma AG, Kannalife, Inc., Molnlycke Health Care, Intermed Pharmaceuticals, DermaSciences, Inc., ConvaTec Group PLC, BMG Pharma S.r.l., and Acelity, Inc. (3M).

Market Taxonomy

By Product
  • Topical
  • Corticosteroids
  • Hydrophilic Creams
  • Antibiotics
  • Others
  • Oral
  • Dressings
  • No Sting barrier film
  • Silicone Coated dressings
  • Honey impregnated gauze
  • Others
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Table of Contents

141 Pages
1 Introduction
1.1 Objectives of the Study
1.2 Market definition
1.3 Market scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Radiodermatitis Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porter's Five Force Model
4.4 Value Chain Analysis
5 Global Radiodermatitis Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Global Radiodermatitis Market Share Analysis, By Product
5.3 Global Radiodermatitis Market Size and Forecast, By Product
5.3.1 Topical
5.3.1.1 Corticosteroids 5.3.1.2Hydrophillic Creams
5.3.1.3Antibiotics
5.3.1.4Others
5.3.2 Oral
5.3.3Dressings
5.3.3.1No String barrier film
5.3.3.2 Silicone Coated dressings
5.3.3.3 Honey-impregnated gauze
5.3.3.4Others
6 Global Radiodermatitis Market, By Distribution Channel
6.1 Y-o-Y Growth Comparison, By Distribution Channel
6.2 Global Radiodermatitis Market Share Analysis, By Distribution Channel
6.3 Global Radiodermatitis Market Size and Forecast, By Distribution Channel
6.3.1 Hospital Pharmacy
6.3.2 Retail Pharmacy
6.3.3 Others
7Global Radiodermatitis Market, By Region
7.1 Global Radiodermatitis Market Share Analysis, By Region
7.2 Global Radiodermatitis Market Share Analysis, By Region
7.3 Global Radiodermatitis Market Size and Forecast, By Region
8 North America Radiodermatitis Market Analysis and Forecast (2022–2027)
8.1 Introduction
8.2 North America Radiodermatitis Market Share Analysis, By Product
8.3 North America Radiodermatitis Market Size and Forecast, By Distribution Channel
8.4 North America Radiodermatitis Market Size and Forecast, By Country
8.4.1 U.S.
8.4.2 Canada
8.4.3 Mexico
9Europe Radiodermatitis Market Analysis and Forecast (2022 – 2027)
9.1 Introduction
9.2 Europe Radiodermatitis Market Share Analysis, By Product
9.3 Europe Radiodermatitis Market Size and Forecast, By Distribution Channel
9.4 Europe Radiodermatitis Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10 Asia Pacific Radiodermatitis Market Analysis and Forecast (2022–2027)
10.1 Introduction
10.2 Asia Pacific Radiodermatitis Market Share Analysis, By Product
10.3 Asia Pacific Radiodermatitis Market Size and Forecast, By Distribution Channel
10.4 Asia Pacific Radiodermatitis Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11Latin America Radiodermatitis Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Latin America Radiodermatitis Market Share Analysis, By Product
11.3 Latin America Radiodermatitis Market Size and Forecast, By Distribution Channel
11.4 Latin America Radiodermatitis Market Size and Forecast, By Country
12 Middle East Radiodermatitis Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Middle East Radiodermatitis Market Share Analysis, By Product
12.3 Middle East Radiodermatitis Market Size and Forecast, By Distribution Channel
12.4 Middle East Radiodermatitis Market Size and Forecast, By Country
13Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14Company Profiles
15.1 Jay Pharma
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Smith & Nephew Plc
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Stratpharma AG
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Kannalife, Inc.
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Molnlycke Health Care
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Intermed Pharmaceuticals
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 DermaSciences, Inc.
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 ConvaTec Group PLC
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 BMG Pharma S.r.l.
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Acelity, Inc. (3M)
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us